Pharmaron (03759.HK) announced on June 19th that it issued $300 million zero-interest convertible bonds due in 2026.

The company hereby announces that, according to the terms and conditions of the first batch of US dollar bonds, bondholders holding a total principal amount of $218.9 million of the first batch of US dollar bonds, accounting for approximately 72.97% of the total principal amount of the first batch of US dollar bonds issued and approximately 99.32% of the current outstanding principal amount of the first batch of US dollar bonds, have exercised their option and requested the company to redeem all of its first batch of US dollar bonds on June 18, 2024.

As of the date of this announcement, all of the first batch of US dollar bonds have been redeemed and canceled. The outstanding principal amount of the first batch of US dollar bonds after redemption is $1.5 million. If the group repurchases or redeems the remaining $1.5 million of the first batch of US dollar bonds, the group will apply to The Stock Exchange of Hong Kong Limited for the withdrawal of the listing status of the first batch of US dollar bonds and issue an announcement in this regard.